L F J van Overveld1, J C C Braspenning1,2, R P M G Hermens1. 1. Scientific Institute for Quality of Healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. 2. The Netherlands Federation of University Medical Centres, NFU, Utrecht, The Netherlands.
Abstract
OBJECTIVES: Oncological care is very complex, and delivery of integrated care with optimal alignment and collaboration of several disciplines is crucial. To monitor and effectively improve high-quality integrated oncological care, a dashboard of valid and reliable quality indicators (QIs) is indispensable. The aim was to develop multidisciplinary QIs to measure quality of integrated oncological care, specifically for head and neck cancer (HNC) patients. DESIGN: The RAND-modified Delphi method was used to decide on the outcome, process and structure QIs form three different perspectives. In addition, case-mix factors were determined. SETTING: Integrated HNC in the Netherlands. PARTICIPANTS: Head and neck cancer patients, chairmen of both patient organisations and medical specialists and allied health professionals involved in HNC care in the Netherlands. MAIN OUTCOME MEASURES: Outcome, process and structure indicators. RESULTS: Outcome indicators were assigned to healthcare status, tumour recurrence, complications, quality of life and patient experiences. The process indicators focused on the (allied health) care aspects during the diagnostic, treatment and follow-up phases, for example regarding waiting times, multidisciplinary team meetings and screening for the need of allied health care. CONCLUSIONS: This is the first set of multidisciplinary QIs for HNC care, to assess quality of integrated care agreed by patients and professionals. This set can be used to build other oncological quality dashboards for integrated care.
OBJECTIVES: Oncological care is very complex, and delivery of integrated care with optimal alignment and collaboration of several disciplines is crucial. To monitor and effectively improve high-quality integrated oncological care, a dashboard of valid and reliable quality indicators (QIs) is indispensable. The aim was to develop multidisciplinary QIs to measure quality of integrated oncological care, specifically for head and neck cancer (HNC) patients. DESIGN: The RAND-modified Delphi method was used to decide on the outcome, process and structure QIs form three different perspectives. In addition, case-mix factors were determined. SETTING: Integrated HNC in the Netherlands. PARTICIPANTS: Head and neck cancerpatients, chairmen of both patient organisations and medical specialists and allied health professionals involved in HNC care in the Netherlands. MAIN OUTCOME MEASURES: Outcome, process and structure indicators. RESULTS: Outcome indicators were assigned to healthcare status, tumour recurrence, complications, quality of life and patient experiences. The process indicators focused on the (allied health) care aspects during the diagnostic, treatment and follow-up phases, for example regarding waiting times, multidisciplinary team meetings and screening for the need of allied health care. CONCLUSIONS: This is the first set of multidisciplinary QIs for HNC care, to assess quality of integrated care agreed by patients and professionals. This set can be used to build other oncological quality dashboards for integrated care.
Authors: Larissa Nekhlyudov; Michelle A Mollica; Paul B Jacobsen; Deborah K Mayer; Lawrence N Shulman; Ann M Geiger Journal: J Natl Cancer Inst Date: 2019-11-01 Impact factor: 13.506
Authors: Lydia F J van Overveld; Robert P Takes; Thomas W Vijn; Jozé C C Braspenning; Jan P de Boer; John J A Brouns; Rolf J Bun; Boukje A C van Dijk; Judith A W F Dortmans; Emilie A C Dronkers; Robert J J van Es; Frank J P Hoebers; Arvid Kropveld; Johannes A Langendijk; Ton P M Langeveld; Sjoukje F Oosting; Hendrik P Verschuur; Jan G A M de Visscher; Stijn van Weert; Matthias A W Merkx; Ludi E Smeele; Rosella P M G Hermens Journal: Health Expect Date: 2017-06-15 Impact factor: 3.377
Authors: Merel L Kimman; Adrienne H Rotteveel; Marlies Wijsenbeek; Rémy Mostard; Nelleke C Tak; Xana van Jaarsveld; Marjolein Storm; Kioa L Wijnsma; Marielle Gelens; Nicole C A J van de Kar; Jack Wetzels; Carmen D Dirksen Journal: Patient Date: 2017-10 Impact factor: 3.883
Authors: Jaap Ten Oever; Joëll L Jansen; Thomas W van der Vaart; Jeroen A Schouten; Marlies E J L Hulscher; Annelies Verbon Journal: J Antimicrob Chemother Date: 2019-11-01 Impact factor: 5.790
Authors: Sebastian Adeberg; Christina Sauer; Lena Lambert; Sebastian Regnery; Paul Windisch; Karim Zaoui; Christian Freudlsperger; Julius Moratin; Benjamin Farnia; Christoph Nikendei; Juergen Krauss; Johannes C Ehrenthal; Rami El Shafie; Juliane Hörner-Rieber; Laila König; Sati Akbaba; Kristin Lang; Thomas Held; Stefan Rieken; Juergen Debus; Hans-Christoph Friederich; Imad Maatouk Journal: Front Psychol Date: 2021-12-16
Authors: Annemieke Kok; Carlijn van der Lugt; Marja J Leermakers-Vermeer; Nicole M de Roos; Caroline M Speksnijder; Remco de Bree Journal: Eur J Cancer Care (Engl) Date: 2021-10-12 Impact factor: 2.328
Authors: Robert P Takes; Gyorgy B Halmos; John A Ridge; Paolo Bossi; Matthias A W Merkx; Alessandra Rinaldo; Alvaro Sanabria; Ludi E Smeele; Antti A Mäkitie; Alfio Ferlito Journal: Curr Oncol Rep Date: 2020-07-10 Impact factor: 5.075
Authors: Ann-Jean C C Beck; Jacobien M Kieffer; Valesca P Retèl; Lydia F J van Overveld; Robert P Takes; Michiel W M van den Brekel; Wim H van Harten; Martijn M Stuiver Journal: PLoS One Date: 2019-12-13 Impact factor: 3.240